NCT00153907 Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT00151047 Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer Status COMPLETED Phase PHASE2
NCT00148135 Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site Status TERMINATED Phase PHASE2
NCT00148122 A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00146588 Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer Status COMPLETED Phase NA
NCT00142480 Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer Status COMPLETED Phase PHASE2
NCT00130936 Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates Status TERMINATED Phase PHASE1/PHASE2
NCT00130533 Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients Status COMPLETED Phase PHASE3
NCT00130507 Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab Status TERMINATED Phase PHASE2
NCT00129935 EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer Status COMPLETED Phase PHASE3
NCT00124566 Study of Irofulven in Patients With Hormone-refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00123851 Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00122291 A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer Status UNKNOWN Phase PHASE2
NCT00121836 A Study of Xeloda (Capecitabine) in Women With HER2-Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE4
NCT00121277 Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors Status COMPLETED Phase PHASE1
NCT00121251 Sorafenib, Gemcitabine, and Capecitabine in Treating Patients With Unresectable and/or Metastatic Kidney Cancer Status COMPLETED Phase PHASE1/PHASE2